ArticleGastroenterology research and practice2018

Comparison of Concomitant Mesalamine and Immunomodulator Therapy and Immunomodulator Monotherapy for Crohn's Disease.

Min Seob Kwak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.